Airway Basal Stem Cells Inflammatory Alterations in COVID-19 and Mitigation by Mesenchymal Stem Cells.

Cell Prolif · 2025 · PMC12179551 · PMID 39865778

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the MSC (i.v.) group, there was a reduction in overall inflammation compared to the COVID‐19 group, but the difference did not reach statistical significance (Figure 5B,C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.